Intelligence Platform
Patents
Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6287575
Vaccine against papillomatous digital dermatitis (PDD)
expired patentUS 6284536
Modified immunoglobin molecules and methods for use thereof
expired patentUS 6280964
Binding sites for phosphotyrosine binding domains
expired patentUS 6277368
Cancer immunotherapy using autologous tumor cells combined with cells expressing a membran
expired patentUS 6277585
Netrin receptors
expired patentUS 6277586
Cloned glutamic acid decarboxylase
expired patentUS 6274116
Compositions for boron delivery to mammalian tissue
expired patentUS 6270995
Recombinant polynucleotides encoding a slit polypeptide
expired patentUS 6270747
In vitro and in vivo assay for agents which treat mucus hypersecretion
expired patentUS 6270954
Correction of genetic defects using chemical chaperones
expired patentUS 6270979
Methods for anti-addictive narcotic analgesic treatments
expired patentUS 6270984
Modulating robo: ligand interactions
expired patentUS 6267960
PSCA: prostate stem cell antigen
expired patentUS 6268348
Synthetic compounds and compositions with enhanced cell binding
expired patentUS 6268352
Promoters of neural regeneration
expired patentUS 6268194
IKB kinase and methods of using same
expired patentUS 6266622
Nuclear receptor ligands and ligand binding domains
expired patentUS 6265563
Opioid receptor genes
expired patentUS 6265192
Glycosly sulfortransferase-3
expired patentUS 6265175
Method for production of neuroblasts
expired patentUS 6261789
Methods for detecting the presence of a PSCA protein using PSCA antibodies
expired patentUS 6262235
Leptospiral outer membranes protein, LipL46
expired patentUS 6261791
Method for diagnosing cancer using specific PSCA antibodies
expired patentUS 6258939
PSCA antibodies and hybridomas producing them
expired